Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16
Closed 368
2022
Q3
$0 Hold
16
﹤0.01% 1161
2022
Q2
$0 Hold
16
﹤0.01% 1159
2022
Q1
$1K Hold
16
﹤0.01% 1097
2021
Q4
$1K Hold
16
﹤0.01% 1098
2021
Q3
$0 Hold
16
﹤0.01% 1132
2021
Q2
$1K Hold
16
﹤0.01% 1092
2021
Q1
$1K Hold
16
﹤0.01% 1083
2020
Q4
$1K Sell
16
-418
-96% -$11.8K ﹤0.01% 932
2020
Q3
$8K Sell
434
-14
-3% -$244 ﹤0.01% 587
2020
Q2
$7K Buy
448
+432
+2,700% +$6.57K ﹤0.01% 588
2020
Q1
$145 Hold
16
﹤0.01% 1095
2019
Q4
$340 Sell
16
-32
-67% -$710 ﹤0.01% 1215
2019
Q3
$1.1K Buy
+48
New +$1.09K ﹤0.01% 1297

Other funds holding ADNT

Evoke Wealth's ADNT Position: Q4 2022 in Review

Evoke Wealth sold out of Adient (ADNT) in Q4 2022, closing a stake of 16 shares.

Evoke Wealth first reported a position in ADNT in Q3 2019 and held it in 13 quarters. The position peaked at $8K in Q3 2020. 273 funds tracked by Wall St. Rank hold ADNT as of Q4 2022.

  • Evoke Wealth reported no remaining Adient position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 16 Adient shares in Q4 2022.
  • Evoke Wealth first reported a position in Adient in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Adient position peaked at $8K in Q3 2020.
  • 273 funds tracked by Wall St. Rank held Adient as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.